The five-year survival rate for those with pancreatic cancer is just over 9%. Pancreatic cancer is also the eleventh most common type of cancer in the United States, representing 3.2% of all new cancer diagnoses every year. Standard treatment avenues for cancer, such as chemotherapy and radiation, have limited effectiveness in pancreatic cancer patients.īased on current SEER data from the National Cancer Institute, there were an estimated 56,770 new cases of pancreatic cancer diagnosed in the U.S. There is no screening test available to identify the disease, and because there may be no symptoms present, it is often diagnosed at an advanced stage, after the cancer has spread to other organs in the body. Pancreatic cancer is an aggressive disease that is difficult to detect. Synopsis of Open Program Funding Opportunities.Psychological Health/Traumatic Brain Injury.Clinical and Rehabilitative Medicine Research Program (JPC-8).Radiation Health Effects Research Program (JPC-7).Combat Casualty Care Research Program (JPC-6).Military Operational Medicine Research Program (JPC-5).Military Infectious Diseases Research Program (JPC-2).Medical Simulation and Information Sciences Research Program (JPC-1).

Defense Medical Research and Development.

Additional Supported DOD Programs/Projects.Traumatic Brain Injury and Psychological Health.

Download diagnosing pancreatic cancer